Lisa Chiang is an Infectious Disease physician affiliated with The Lundquist Institute. OpenAlex indexes 10 publications with 936 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9449 Imperial Hwy Ste C120
Downey, CA 902422814
Telephone
562-657-4684Provider last certified this registry record 11 Nov 2021.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Shionogi IncProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
73.3%Tetracycline-class Drug14.7%Doxycycline Monohydrate100%Part D≥11 patientsCephalosporin Antibacterial12.7%Cefpodoxime Proxetil100%Part D<11 patients+ 5 more classes in this area
Cardiovascular
18.7%Statin11.3%Atorvastatin Calcium100%Part D<11 patientsCalcium channel blocker7.3%Amlodipine Besylate100%Part D<11 patientsSensory organs
8%Fluoroquinolone Antibacterial8%Ciprofloxacin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2005–2009 per NIH RePORTER. The latest:
- CHARACTERIZING THE ADHERENCE OF ASPERGILLUS FUMMIGATUS TO ENDOTHELIAL CELLS
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2009$3,490M01RR000425 - CHARACTERIZING THE ADHERENCE OF ASPERGILLUS FUMMIGATUS TO ENDOTHELIAL CELLS
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2008$7,894M01RR000425 - CHARACTERIZING THE ADHERENCE OF ASPERGILLUS FUMMIGATUS TO ENDOTHELIAL CELLS
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
FY2007$5,023M01RR000425
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Aspergillus fumigatus AcuM regulates both iron acquisition and gluconeogenesis
Molecular Microbiology
2010 - <i>Aspergillus fumigatus</i>MedA governs adherence, host cell interactions and virulence
Cellular Microbiology
2009 - Gliotoxin Production in<i>Aspergillus fumigatus</i>Contributes to Host‐Specific Differences in Virulence
The Journal of Infectious Diseases
2008
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”